US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Gelteq Pty Ltd

us-stock
To Invest in {{usstockname}}
us-stock
$1.07 0(0%) GELS at 04 Dec 2025 04:33 PM Drug Manufacturers - Specialty & Generic
Lowest Today 1.06
Highest Today 1.12
Today’s Open 1.07
Prev. Close 1.08
52 Week High 5.50
52 Week Low 0.77
Day’s Range: Low 1.06 High 1.12
52-Week Range: Low 0.77 High 5.50
1 day return -
1 Week return -2.7
1 month return +0.93
3 month return +12.5
6 month return -36.84
1 year return -53.44
3 year return -
5 year return -
10 year return -

Institutional Holdings

Market Status

Fundamentals

Market Cap 11.57 M

PB Ratio 1.122

PE Ratio 0.0

Enterprise Value 14.09 M

Total Assets 21.48 M

Volume 69264

Company Financials

Annual Revenue FY25:165645 0.2M, FY24:0 0.0M

Annual Profit FY25:null 0.0M, FY24:0 0.0M

Annual Net worth FY25:-6645453 -6.6M, FY24:-3546195 -3.5M

Quarterly Revenue Q2/2024:0 0.0M

Quarterly Profit Q2/2024:0 0.0M

Quarterly Net worth Q2/2024:-1133132 -1.1M

Fund house & investment objective

Company Information Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Organisation Drug Manufacturers - Specialty & Generic

Employees 7

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Nathan Jacob Givoni

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right